Serum microRNA-139-5p is a biomarker of bone metastasis in lung cancer patient

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：huangjl41

【摘要】

：

　　Objective: Lung cancer is the leading cause of cancer mortality worldwide.About 30-40% of patients with lung cancer developed bone metastasis during the cou

【作者】

：

Song Xu Yi Wu Renwang Liu Haiyang Fan Sen Wei Gang Chen Qinghua Zhou Jun Chen

【机构】

：

Department of Lung Cancer Surgery, Tianjin Medical University General Hospital

【出处】

：

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会

【发表日期】

：

2015年期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective: Lung cancer is the leading cause of cancer mortality worldwide.About 30-40% of patients with lung cancer developed bone metastasis during the course of their disease, with the median survival time of 7 months approximately.

其他文献

多西紫杉醇与奈达铂联合重组人血管内皮抑素静脉泵入在晚期非小细胞肺癌治疗中的临床观察

　　目的：探讨多西紫杉醇联合奈达铂与重组人血管内皮抑素(恩度)静脉泵入在晚期非小细胞肺癌(NSCLC)治疗中的疗效及安全性。方法：2012年3月至2014年1 1月在我科治疗的32例Ⅳ期N

会议

多西紫杉醇奈达铂重组人血管内皮抑素静脉泵入晚期非小细胞肺癌肺癌治疗疗效及安全性NSCLC

Icotinib for control of leptomeningeal carcinomatosis in non-small cell lung cancer with sensitive E

　　目的： The incidence rate of leptomeningeal carcinomatosis (LC) has been increased in advanced non-smaU cell lung cancer (NSCLC) patients, especially with EGF

会议

EGFRlung cancercellincidence rateespeciallyNSCLCThe

肺鳞癌成纤维细胞生长因子受体1表达与临床因素的关系

　　目的：目前肺鳞癌缺乏有效的分子靶向药物，以成纤维细胞生长因子受体1(FGFR1)为靶点的药物正在国内进行Ⅰ期临床研究，而国内关于FGFR1基因拷贝数报道较少。本研究中国肺鳞癌

会议

肺鳞癌成纤维细胞生长因子受体mRNA表达临床因素基因拷贝数FGFR1分子靶向药物临床研究

EGFR mutation is associated with histologic subtype according to the IASLC/ATS/ERS adenocarcinoma cl

　　目的： In 2011, the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society (IASLC/ATS/ERS) propose

会议

theEGFRATSclassificationERSlung adenocarcinomaSocietyInternational

Intercalated Treatment of Advanced Non-Small Cell Lung Cancer Patients with Gradual Progression afte

　　Objective: To observe the PFS (Progression Free Survival) could be extended inadvanced non-small cell lung cancer patients with gradual progression after fa

会议

Depression Reduces Progression-free Survival of Platinum-based Chemotherapy in Patients with Lung Ad

　　Objective: As a poor prognostic cancer, lung cancer which has serious impact on psychological of patients.The patient offen involed in a state of depression

会议

Different Adaptive Response Induced by Low-dose Radiation in Normal Lung Cells and Lung Cancer Cells

　　Objective: Low-dose radiation (LDR) has been proposed to induce an adaptive response in normal cells but not in tumor cells, which may protect normal tissue

会议

Prognostic significance of KRT 19 in lung cancer

　　Objective: Lung cancer is a heterogeneous group of malignancies with variable prognosis and is divided into two main groups, small cell lung cancer (SCLC) a

会议

Notch3 promotes chemoresistance by upregulting ALDH1 A1 and CD44 and induces autophagy in non-small

　　Objective: Acquiredresistance to standard chemotherapy causes treatment failure in patients with advanced non-small lung cancer (NSCLC).Cancer stem cells (C

会议

The treatment with dose-escalated icotinib after resistance to routine dose of icotinib for the pati

　　Objective: To evaluate the efficacy of treatment with dose-escalated icotinib after resistance to routine dose of icotinib for the patients of the advanced

会议

Serum microRNA-139-5p is a biomarker of bone metastasis in lung cancer patient

与本文相关的学术论文